ZEOX
Zeo ScientifiX, Inc.Substantial doubt about the company's ability to continue as a going concern.
“As of April 30, 2026, based on the factors described above, the Company concluded that there was substantial doubt about its ability to continue to operate as a going concern for the 12 months following the issuance of these financial statements.”View the 10-Q filed Jun 15, 2026
One customer — 15.2% of revenue (the six months ended April 30, 2025)
“$341,000 (15.2%) and $228,000 (10.2%) to two individual medical practices”
One customer — 14.2% of revenue (the six months ended April 30, 2026)
“During the six months ended April 30, 2026, the Company sold products and services totaling approximately $571,000 (14.2%) to a large medical practice group and distributor”
One customer — 12.7% of revenue (the six months ended April 30, 2026)
“approximately $511,000 (12.7%) to another large medical practice group and distributor”
One customer — 12.1% of revenue (the six months ended April 30, 2025)
“During the six months ended April 30, 2025, the Company sold products and services totaling approximately $270,000 (12.1%) to a large distributor”
One customer — 10.2% of revenue (the six months ended April 30, 2025)
“$341,000 (15.2%) and $228,000 (10.2%) to two individual medical practices”
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
No Fails to Deliver Data
No fails-to-deliver data is available for this stock yet.